Parexel logo

Parexel

Last updated: . For recent data, use our API.

Overview

Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals collaborates with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers the best solutions to make every phase of the clinical trial process more efficient. With the people, insight and focus on operational excellence, we work every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference. For more information, visit parexel.com.

Community Guidelines

Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are:

• Abusive, harassing or threatening to others.

• Defamatory, offensive, obscene, vulgar or depicting violence.

• Hateful targeting by race/ethnicity, age, color, creed, religion, gender,

sexual preference or orientation, nationality or political beliefs.

• Sexually explicit or pornographic.

• Fraudulent, deceptive, libelous, misleading or unlawful.

• Referencing criminal or illegal activity.

• Spamming.

We reserve the right to remove any comments that do not adhere to our guidelines as well as report users who violate the rules of our page.

Funding rounds

2 rounds. Latest: Venture Round, 1 Jan 1990.

DateTypeAmount
1 Jan 1990Venture RoundNot disclosed
More funding rounds via API
Get company data via API

Get company records through the Enrich Layer API. These pages show previews only.

Office locations

Latest videos from Parexel on YouTube

  • What Work-Life Balance looks like as a Senior Regulatory Affairs Associate at Parexel
  • A Journey through Academia, Big Pharma and Biotech: Building Breakthrough Medicines with Dr. Briggs
  • CTB Podcast VIDEO Reenie McCarthyOvercoming Hurdles in Rare Disease Therapy with Reenie McCarthy
  • How to Prepare for a Video Interview | Tips from Parexel Recruiters
View channel

Recent posts from the Parexel blog

  • Breakthrough therapies don't happen in isolation.

    They are built through strong science, strategic partnerships and shared purpose. Yesterday, we welcomed biotech innovators, founders and academic leaders to Parexel's Raleigh headquarters to kick off the Parexel Biotech Incubator.

  • Parexel's Gonzalo M.

    Moreno, Associate Director, Site Activation, recently joined CBS 17 (WNCN) for an interview alongside Blood Cancer United's Lexie Petsikas. During the conversation, Gonzalo shared his experience as a blood cancer survivor who was treated for Acute Lymphoblastic Leukemia (ALL) and discussed why he is passionate about supporting Blood Cancer United and Light the Night, the organization's annual fundraising event.

Parexel FAQ

As of 2026-10-20, Parexel has 17,760 employees, based on the Enrich Layer count of person profiles that list Parexel as their current employer. Its listed company size band is 10,001+.
As of 2026-10-20, Parexel is headquartered in Durham, North Carolina, US.
As of 2026-10-20, Parexel is classified in the Pharmaceutical Manufacturing industry.
Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals collaborates with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers the best solutions to make every phase of the clinical trial process more efficient. With the people, insight and focus on operational excellence, we work every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference. For more information, visit parexel.com.
As of 2026-10-20, Parexel's official website is http://www.parexel.com/.
As of 2026-10-20, Parexel is a privately held company.